ArticleEClinicalMedicine2020

Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study.

Maria Rosario Capeding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.